Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2021-05-10 AGM Information
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 1% confidence The document explicitly states it is a 'SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB'. It details resolutions passed regarding the approval of financial statements, dividend policy, election of the Board of Directors, auditor appointment, approval of remuneration reports, and the adoption of incentive programs (stock options/warrants). These are all typical outcomes and discussions held during an Annual General Meeting (AGM). Therefore, the classification should be AGM Information (AGM-R).
2021-05-10 English
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 1% confidence The document is titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)" which translates to "COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING IN EPISURF MEDICAL AB (PUBL)". The text details the resolutions passed at the Annual General Meeting (Årsstämma) held on May 10, 2021, including the approval of financial statements, election of the board, approval of remuneration, and decisions regarding incentive programs (stock options). This content directly corresponds to the materials and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information).
2021-05-10 Swedish
New European patent approval for Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces a specific corporate event: the intention to grant a new European patent for Episurf Medical related to its Episealer® implant. This is a specific, non-financial, operational/legal update. It is not an Annual Report (10-K), Earnings Release (ER), or a comprehensive financial report (IR). It is too specific for a general Regulatory Filing (RNS) or a Legal Proceedings Report (LTR), as it concerns intellectual property acquisition rather than litigation. Since there is no specific category for 'Patent Approval Announcement,' and it is a material announcement that doesn't fit the other specific categories (like M&A, Director Dealing, Dividend), the most appropriate fallback category is Regulatory Filings (RNS), as it is a mandatory disclosure under EU Market Abuse Regulation.
2021-04-29 English
Nytt patentbeviljande i Europa för Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces that the European Patent Office (EPO) intends to grant a new European patent to Episurf Medical for an implant feature. It includes commentary from the COO regarding intellectual property (IP) protection. The text concludes with a statement that this information is required to be made public under the EU's Market Abuse Regulation (MAR) and was released at a specific time. This type of announcement, concerning intellectual property rights (patents) and regulatory disclosure, does not fit neatly into the primary financial reporting categories (10-K, IR, ER, etc.). Since it is a specific regulatory disclosure that doesn't match other defined categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2021-04-29 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Kvartalsrapport 1 januari – 31 mars 2021' (Quarterly Report for Q1 2021). It contains detailed financial statements, including income statements, balance sheet data, management commentary, and operational highlights for the specified period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-04-29 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report 1 January – 31 March 2021' and contains comprehensive financial statements, management commentary, and operational updates for the first quarter of 2021. It provides actual financial data (net sales, loss for the period, earnings per share) and is not merely an announcement or a certification. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2021
2021-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.